000			01060 a2200289 4500
005			20250510211819.0
264		0	_c19790124
008			197901s 0 0 eng d
022			_a0036-7672
040			_aNLM _beng _cNLM
100	1		_aMason, D T
245	0	0	_aAfterload reduction in the treatment of cardiac failure. _h[electronic resource]
260			_bSchweizerische medizinische Wochenschrift _cNov 1978
300			_a1695-703 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aHeart Failure _xdrug therapy
650	0	4	_aHumans
650	0	4	_aHydralazine _xtherapeutic use
650	0	4	_aNitroglycerin _xtherapeutic use
650	0	4	_aNitroprusside _xtherapeutic use
650	0	4	_aPhentolamine _xtherapeutic use
650	0	4	_aPrazosin _xtherapeutic use
650	0	4	_aVasodilator Agents _xtherapeutic use
650	0	4	_aVenous Pressure _xdrug effects
773	0		_tSchweizerische medizinische Wochenschrift _gvol. 108 _gno. 44 _gp. 1695-703
999			_c99937 _d99937